Established that CGN is a post-transcriptionally regulated suppressor of cell motility, defining its link to RhoA/ROCK signaling in cancer.
Evidence dual-luciferase 3'UTR reporter, miR-125b/CGN overexpression and knockdown, migration/invasion assays and xenografts in colorectal cancer cells
- the molecular step by which CGN restrains RhoA is not defined (no GEF/GAP or direct binding partner identified)
- link is correlative for the signaling axis rather than reconstituted
- generality beyond colorectal cancer untested at this point